| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.02B | -1.3% |
| Cost of Revenue | $314.6M | -4.5% |
| Gross Profit | $707.2M | +0.2% |
| R&D Expense | $155.8M | -15.1% |
| SG&A Expense | $469.2M | -0.6% |
| Operating Income | -$76.8M | -9689.8% |
| Interest Expense | $48.3M | -3.8% |
| Pre-tax Income | -$75.1M | +39.6% |
| Income Tax | $11.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $214.2M | +3.0% |
| Accounts Receivable | $183.1M | -1.2% |
| Inventory | $129.4M | +22.2% |
| Current Assets | $886.1M | +30.5% |
| Total Assets | $2.29B | +4.3% |
| Current Liabilities | $297.4M | -57.3% |
| Long-term Debt | $539.0M | +127.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $69.9M | -31.8% |
| Capital Expenditures | $26.5M | +4.1% |
| Investing Cash Flow | -$38.4M | -204.1% |
| Financing Cash Flow | $280.1M | +254.4% |
| Free Cash Flow | $43.4M | -43.7% |
| -1.3% |
| Net Income | -$86.2M | +36.5% |
| EPS (Basic) | -$1.61 | +39.9% |
| EPS (Diluted) | -$1.61 | +39.9% |
| Total Liabilities |
| $1.09B |
| +20.0% |
| Stockholders' Equity | $1.21B | -6.7% |